BOTHELL, Wash., March 29, 2018 /PRNewswire/ — AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the addition of a new building complex that will house the company's global headquarters in Bothell, Washington.

The new complex is located adjacent to the existing AGC Biologics facility in Bothell, and spans more than 150,000 square feet (more than 14,000 square meters). The complex will hold the company's process development labs and corporate administrative offices, and will provide expansion space for additional manufacturing capacity.

The new facilities allow AGC Biologics to continue its expansion in the United States, and will include a new R&D center dedicated to novel manufacturing technologies for faster development of therapeutic proteins.

"The expansion of our Bothell site is another substantial milestone for AGC Biologics and a commitment to our operations in Washington State. We continue to demonstrate our dedication to sustained growth in order to support our customers' increasing demand for both mammalian and microbial development and manufacturing services," said Gustavo Mahler, President and CEO of AGC Biologics. "These new state-of-the-art facilities will enable us to meaningfully advance and further integrate the development, manufacturing, and commercial functions within our dynamic global headquarters, as well as provide additional footprint for further manufacturing expansion."